Repatha’s Approval Marks New Chapter in Cholesterol Management

Posted by on

Details

PCSK9 inhibitors have been the focus of the cardiology community and with the approval of two medications in the past few months these drugs could soon make their way to a large number of patients needing help managing their cholesterol levels using more than just statins.

Leave a Reply

You must be logged in to post a comment.